Cleared Traditional

K232354 - Vios Monitoring System(TM) Model 2050

Also marketed or referenced as:
Vios Central Station Monitor/Vios Central Server Software

K232354 is an FDA 510(k) clearance for Vios Monitoring System(TM) Model 2050, manufactured by Murata Vios, Inc.. The device is a Class 2 Cardiovascular device with product code DRT cleared through the Traditional 510(k) pathway after a 228-day FDA review.

K232354 · Murata Vios, Inc. · Cardiovascular device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Mar 2024
Decision
228d
Days
Class 2
Risk

K232354 is an FDA 510(k) clearance for the Vios Monitoring System(TM) Model 2050. Classified as Monitor, Cardiac (incl. Cardiotachometer & Rate Alarm) (product code DRT), Class II - Special Controls.

Submitted by Murata Vios, Inc. (Woodbury, US). The FDA issued a Cleared decision on March 22, 2024 after a review of 228 days - an extended review cycle.

This device falls under the Cardiovascular FDA review panel, regulated under 21 CFR 870.2300 - the FDA cardiovascular device oversight framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the Cardiovascular review framework, consistent with the majority of Class II 510(k) submissions.

View all Murata Vios, Inc. devices

FDA 510(k) Submission Details - K232354

510(k) Number K232354 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received August 07, 2023
Decision Date March 22, 2024
Days to Decision 228 days
Submission Type Traditional
Review Panel Cardiovascular (CV)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Regulatory Context
Review time vs. panel average
103d slower than avg
Panel avg: 125d · This submission: 228d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

DRT Device Classification - Class 2, Special Controls

Product Code DRT Monitor, Cardiac (incl. Cardiotachometer & Rate Alarm)
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 870.2300
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Cardiovascular devices follow this clearance model.

Regulatory Peers - DRT Monitor, Cardiac (incl. Cardiotachometer & Rate Alarm)

All 167
Devices cleared under the same product code (DRT) and FDA review panel - the closest regulatory comparables to K232354.
Sleepiz One+ (Model 2.5)
K253388 · Sleepiz AG · Jan 2026
Sleepiz One+ (2.5)
K251364 · Sleepiz AG · Jul 2025
The Circadia C200 System
K234003 · Circadia Technologies, Ltd. · May 2024
Neteera 130H-Plus Vital Sign Monitoring Sensor
K231733 · Neteera Technologies , Ltd. · Feb 2024
Sleepiz One+
K223163 · Sleepiz AG · Aug 2023
Neteera 130H/131H Vital Sign Monitoring Sensor
K212143 · Neteera Technologies , Ltd. · Sep 2022